CellaVision AB (LTS:0MR5)
kr 239.25 0 (0%) Market Cap: 5.80 Bil Enterprise Value: 5.69 Bil PE Ratio: 37.03 PB Ratio: 7.24 GF Score: 93/100

Q2 2022 CellaVision AB Earnings Call Transcript

Jul 20, 2022 / 09:00AM GMT
Release Date Price: kr358 (+2.87%)
Operator

Good morning, afternoon or evening, and welcome to the CellaVision Q2 2022 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded.

I would now like to turn the conference over to Simon Ostergaard. Please go ahead.

Simon Ostergaard;publ;CEO;President
CellaVision AB

()-&

Thank you very much, and thank you, everybody, for dialing in for this conference call, where we present our results for the first half of 2022. I have Magnus Blixt, our CFO, with me, and we are pleased to have the dialogue and answer any questions you may have at the end of the presentation. But I will start by sharing our quarterly results here. So next slide, please.

The next slide really talks about the second quarter highlights. You can see -- it has not come up -- but I will start sharing.

Okay. Excellent. So here, we have the second quarter highlights. Essentially, the key message here is that we have had a successful second quarter, and in fact, our sales of SEK 184

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot